Iproteome Pty Ltd

Status: Registered
Current name since: 2011-03-30
Name in the ASICs register: Iproteome Pty Ltd
Australian Company Number: 092355989
Australian Business Number: 74092355989
Registration date: 2000-04-06
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Iproteome Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2113 since 2014-07-28 the company is, as the updated on 2014-07-29 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2000-07-01. Known company numbers for Iproteome Pty Ltd are as follows: ACN - 092355989, Australian Business Number - 74092355989. Iproteome Pty Ltd has been the company name since 2011-03-30. Their official company name changed on 2003-11-03 to Minomic Pty Ltd. The company had used this name up until 2011-03-30. Additionally they had used Proteomeca Pty Ltd from 2002-08-02 to 2003-11-03, Arcadia Proteomics Pty Ltd from 2000-04-18 to 2002-08-02. This Australian proprietary company was previously located in NSW 2086 (from 2009-08-07 to 2014-07-28), NSW 2067 (from 2006-06-29 to 2009-08-07), NSW 2067 (from 2006-06-26 to 2006-06-29). AUBiz found 1 trademark that reference the abovementioned company. 2005-09-28 is the date the documents needed to start the registration process of trademark no 1078044 were submitted. This trademark is categorised as "composite" and its application status is "registered, live".

Details for ABN 74092355989

Type: Australian Private Company

ABN Status

Status From To
Active 2000-04-10 current

Main Name

Name From To
Iproteome Pty Ltd 2011-03-30 current
Minomic Pty Ltd 2003-11-03 2011-03-30
Proteomeca Pty Ltd 2002-08-02 2003-11-03
Arcadia Proteomics Pty Ltd 2000-04-18 2002-08-02

Main Location

Location From To
NSW 2113 2014-07-28 current
NSW 2086 2009-08-07 2014-07-28
NSW 2067 2006-06-29 2009-08-07
NSW 2067 2006-06-26 2006-06-29
NSW 2086 2006-06-08 2006-06-26
NSW 2096 2000-04-18 2006-06-08

Goods & Services Tax (GST)

Status From To
Registered 2000-07-01 current


Company Trademarks

Trademark number: 1078044

General information:
Application date: 2005-09-28
Lodgement date: 2005-09-28
Registered date: 2005-09-28
Live or dead: Live
CPI status: Registered
Status: Registered/Protected - Renewal Due
Mark code: Trade Mark
Trademark type: Composite
Acceptance due date: 2006-08-18
Sealing due date: 2007-02-28
Registered from date: 2005-09-28
Sealing date: 2006-12-11
Renewal due date: 2015-09-28
Court orders: No
Revocation of the acceptance: No
Lodgement type: National
Descriptive: Mi
Device phrases: Crescent Beside Ltrs
Examination report number: 1
Examination class count: 4
NICE class code: 42
NICE occ number: 1
NICE description text: Scientific And Technological Services Relating To Analysis Of Biological Materials And Samples Including Detection Of Biological Markers Such As Proteins And Peptides; Development Of Assays And Tests For Biological Markers
Applicant information:
Suburb name: Frenchs Forest
Postcode: 2096
Australian state code: NSW
Country code: AU
Attorney information:
Attorney code: 391839
Agency code: B2
Transaction type: Address for service of the trademark
Suburb name: Sydney
Postcode: 2000
Australian state codee: NSW
Attorney type: Attorney
Country code: AU

Find company

NSW 2113 Location

2022 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2022 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2022, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.